Europe medicines agency considering 4 additional COVID-19 vaccines

VOA says Europe’s drug regulator, the European Medicines Agency, said Thursday it is reviewing four additional COVID-19 vaccines and could issue new authorizations before the end of the year.

During a news briefing from the agency’s headquarters in Amsterdam, EMA officials said they are awaiting additional data on Russia’s Sputnik V vaccine and China’s Sinovac Biotech vaccine before the regulator can move forward with reviews of their drugs.

Meanwhile, EMA vaccine strategy chief Marco Cavaleri said the agency has received clinical data from German biotech firm CureVac and U.S. drug maker Novavax, which they will be assessing in coming weeks. He added that the EMA would continue to review data on German biotech firm CureVac’s shot over the next few weeks before a conclusion can be drawn.

https://www.voanews.com/covid-19-pandemic/europe-medicines-agency-considering-4-additional-covid-vaccines